Anti-asthmatics Asthma : is physiologically characterized by increased responsiveness of trachea and bronchi to various stimuli and by widespread narrowing.

Slides:



Advertisements
Similar presentations
ASTHMA A. K. Nayyar. Definition It is a syndrome characterized by AIRFLOW OBSTRUCTION that varies markedly, both spontaneously and with treatment. Narrowing.
Advertisements

Bronchodilators and Other Respiratory Agents
RESPIRATORY PHARMACOLOGY. S+S OF RESPIRATORY CONDITIONS (ASTHMA AND COPD) SOB Cough Wheezing Tight chest.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
Respiratory Care Pharmacology  Application of pharmacology to the treatment of cardiopulmonary disease and critical care.  Involves broad area of drug.
Management of COPD & Asthma Melissa Brittle & Jessica Macaro.
Drugs For Treating Asthma
BRONCHIAL ASTHMA DR.K.PREETHI. RESPIRATORY SYSTEM TRACHEA TRACHEA PAIR OF BRONCHI PAIR OF BRONCHI BRONCHIOLES BRONCHIOLES.
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
Respiratory System PHARMACOLOGY Dr Nasim Ullah Siddiqui.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
Asthma Management Pathophysiology and Management University of Utah Center for Emergency Programs and The Utah Asthma Program.
Drugs Used for the Management of Asthma Jason X.-J. Yuan, M.D., Ph.D. Professor of Medicine and Pharmacology University of Illinois at Chicago Institute.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. BRONCHIAL ASTHMA.
Bronchodilators ( 支气管扩张药 ) Huifang Tang ( 汤慧芳 ) Department of Pharmacology Zhejiang university, school of Medicine
P harmacology RHPT-365 By M ajid A hmad G anaie M. Pharm., P h.D. Assistant Professor Department of Pharmacology E mail: Chapter 5:
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
DRUGS USED IN ASTHMA. Asthma is an inflammatory disease of the airways characterized by episodes of acute bronchoconstriction causing shortness of breath,
Drugs used in asthma & COPD By Dr. Mahmoud A. Naga.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Therapy of bronchial asthma. Management A. Non drug treatment : Avoid exposure to antigen. Avoid humidity. Avoid drugs which precipitate asthma as (parasymathomimetics-
Treatment of asthma By Prof. Hanan Hagar. Disorders of Respiratory Function Classification Main disorders of the respiratory system are : 1. Bronchial.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Bronchodilating Drugs Pat Woodbery, ARNP, CS Professor of Nursing.
1 DRUGS AFFECTING RESPIRATORY SYSTEM. 2 ASTHMA chronic inflammatory airway disease excessive tracheobronchial reactivity SYMPTOMS wheezing, chest tightness,
Drugs used in asthma By S.Bohlooli, PhD. Asthma therapy Short term relievers Bronchodilators Long term controllers Anti-inflammatory agent Leukorienes.
Drugs Affecting the Respiratory System anjie Institute of Pharmacology, School of Medicine, Shandong University.
Bronchodilators Lilley Pharmacology Text: Chapter 35
Clinical pharmacology of drugs acting on the respiratory organs function.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Chapter 9 Respiratory System Drugs Copyright © 2011 Delmar, Cengage Learning.
RESPIRATORY DRUGS CHAPTER 6. ANTITUSSIVES -The cough reflex occurs when receptors in the airway send impulses to the brainstem and cause contraction of.
Pharmacology of drugs used in bronchial asthma & COPD
Bronchodilators and Other Respiratory Agents. Asthma -Predominantly in boys 2:1 -puberty: occurrence equals out -More females in adult-onset cases -Affects.
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
PHL 437/Pharmacogenomics First Lecture (Asthma I) By Abdelkader Ashour, Ph.D. Phone:
Bronchial asthma By Dr. Abdelaty Shawky Assistant professor of pathology.
PHARMACOTHERAPY OF RESPIRATORY DISEASES. Bronchial asthma Bronchial asthma is a disease caused by increased responsiveness of the tracheobronchial tree.
Drugs Affecting Respiratory System. Antihistamines Drugs that directly compete with histamine for specific receptor sites Two histamine receptors –H 1.
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
Plants Used for Respiratory Problems - I. Respiratory Problems Various conditions can interfere with the gas exchange in the lungs Infectious disease.
Disorders Of Respiratory System General Pharmacology M212
Treatment of Bronchial Asthma I D. Laila.M. Matalqah Respiratory System Faculty of Medicine 1.
Course in the Ward Oxygen saturation was 85-88% despite oxygen per mask at 5-6 lpm. She was nebulized with salbutamol and post-nebulization parameters.
Bronchodilators and Other Respiratory Agents
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD).
Clinical pharmacology of drugs acting on the respiratory organs function.
Drugs Used to Treat Asthma Dr. Najlaa Saadi Ismael Department of Pharmacology Mosul college of Medicine University of Mosul.
Asthma Asthma is characterized clinically by recurrent bouts of coughing, shortness of breath, chest tightness, and wheezing; physiologically by.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Department of Pharmacology
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Pharmacology of Anti- Asthmatic Medications
Respiratory System Hmzeh Elayan
Pharmacology of drugs used in bronchial asthma & COPD
Drugs in obstructive lung diseases
Pharmacology of Bronchial Asthma
Chapter 9 Respiratory Drugs.
Drugs affecting the respiratory system
UNIT 8: DRUGS USED IN THE TREATMENT OF RESPIRATORY DISORDERS
RESPIRATORY PHARMACOLOGY
DRUGS AFFECTING THE RESPIRATORY SYSTEM
Chapter 32 Airway Pharmacology
Nonsteroidal antiasthma agents
Drugs Affecting the Respiratory System
Pharmacology of drugs used in bronchial asthma & COPD
Drugs used in asthma.
Presentation transcript:

Anti-asthmatics Asthma : is physiologically characterized by increased responsiveness of trachea and bronchi to various stimuli and by widespread narrowing of the airways.

 The mechanisms underlying bronchial hyperreactivity are somehow related to inflammation of airway mucosa.  The agents that increase bronchial reactivity, such as ozone exposure, allergen inhalation, and infection with respiratory viruses, also cause airway inflammation.

 Its pathologic characters are contraction of airway smooth muscle, mucosal thickening from edema and cellular infiltration, and inspissation in the airway lumen of abnormally thick, viscid plugs of mucus.  The products of cells in the airways, such as eosinophil, lymphocytes, macrophages, mast cells, sensory nerves, and epithelial cells, have been shown to alter airway smooth muscle function.

 Asthma therapies are divided into two categories: short-term relievers and long- term controllers.  short-term relievers: β-adrenoceptor stimulants, theophylline, antimuscarinic agents.  long-term controllers: anti-inflammatory agents, inhibitor of mast cell degranulation.

Ⅰ. Adrenoceptor agonists //mechanism 1. Stimulation of β 2 receptor in bronchial smooth muscle cell mb →cAMP →Ca 2+ ↓ →SM relaxation. 2. Also activateβreceptor on mast cell mb., thus used in prophylaxis of allergic asthma.

3. Stimulation of αreceptor in bronchial vessels contraction of vascular smooth muscle edema. 4. The density of β receptor will decrease after prolonged treatment.

Adrenaline/epinephrine Adrenaline/epinephrine ( 肾上腺素 ): //agonist of α and β receptor //adverse effect of cardiovascular system usually occurs thereby less usable //s.c. injection Ephedrine (麻黄碱) Ephedrine (麻黄碱) //orally administered //similar action to Adr. //less usable for central excitation

Isoproterenol (异丙肾上腺素) //agonist of β 1 &β 2 receptor //no action on α receptor //used for acute attack of bronchoasthma by inspiration route //orally ineffective //involved in adverse effect of β 1 receptor excitation.

 Selectively β 2 receptor agonist Salbutamol ( 沙丁胺醇,舒喘灵 ) Terbutaline (特布他林,博利康尼) Clenbuterol (克仑特罗) Clenbuterol (克仑特罗) The β 2 -Selective adrenoceptor agonist drugs are the most widely used sympathomimetics for the treatment of asthma at the present time.

//Mechanism : Air way smooth muscle has little sympathetic nervous supply but contain lots of ß 2 -adrenoceptors that respond to circulating adrenaline. The stimulation of ß 2 -receptors leads to a rise in intracellular cAMP levels and the subsequent bronchial smooth muscle relaxation

 They are effective after inhaled or oral administration and have a long duration of action and significant β 2 selectivity.  Given by inhalation, these agents cause bronchodilation equivalent to that produced by isoproterenol.

ß 2 -adrenoceptor agonist may also help to prevent the activation of mast cell to prevent the activation of mast cell in a minor degree. in a minor degree. Modern selective ß 2 -receptor agonists are potent bronchodilators and have are potent bronchodilators and have very few ß 1 -stimulating properties. very few ß 1 -stimulating properties.

Route of administration //Route of administration : usually delivered via a metered dose inhaler with immediate effect orally used in children iv used for acute-care. S.C. (terbutaline) Adverse effect //Adverse effect : cardiac arrhythmias tolerance to ß agonist hypoxemia

Ⅱ. Theophylline : derivatives of methylxanthine The importance of theophylline as a therapeutic agent in the treatment of asthma has waned. The importance of theophylline as a therapeutic agent in the treatment of asthma has waned. But theophylline's very low cost is important advantage for economically disadvantaged patients. But theophylline's very low cost is important advantage for economically disadvantaged patients.

They are divided into two types : 1. Salt complex : increased water solubility without augmentation of pharmacological action, such as : aminophylline (氨茶碱) choline theophylline (胆茶碱)

2. Agent of delayed release : small fluctuation of blood concentration after oral administration thus used for nocturnal attact of asthma protheo ( 优喘平)

//Mechanism : Anti-inflammation inhibit activity of PDE cAMP Ca 2+ bronchial relaxation increase the release of NA, Adr inhibition the cell surface receptor of adenosine interfere with the transportation of Ca 2+

//pharmacodynamics  The bronchodilation is the major therapeutic action in asthma.  Potent effects in improving contractility and in reversing fatigue of diaphragm in patients with chronic obstructive lung diseases.  Direct positive chronotropic and inotropic effects on the heart.  In large doses, these agents also relax vascular smooth muscle.

//Administration route : orally effective but different from adrenergic agent for metabolism by P 450 enzyme system //Indications : Bronchial asthma (+βreceptor agonist) Chronic obstructive lung diseases Cardiogenic asthma Sleep apenea syndrom

//Adverse effect : it has a narrow therapeutic window and its therapeutic and toxic effects are related to its plasma concentration. <20mg/L : nausea, vomiting, headache, anxiety, abdominal discomfort 20-40mg/L: arrhythmia

Ⅲ. Muscarinic antagonist : Ipratropium bromide ( 异丙托溴铵 ) Ipratropine( 异丙托品 ) //Mehanism : act by blocking muscarinic receptors esp. the M 3 subtype, which responds to this parasympathetic bronchial constrictor tone.

//Route of administration : metered dose inhaler //Indication : used as adjuncts to ß 2 -adrenoceptor agonist in treatment of asthma and more effective in vagus-induced asthma. //Therapeutic note : synergism when administered with ß 2 -adrenoceptor agonist.

Ⅳ. Anti-inflammatory drug Glucocorticoids include : beclomethasone ( 倍氯米松 ) budesonide (布地奈德) //Mechanism : depress the inflammatory response in bronchial mucosa thus diminish bronchial hyperresponsiveness.

 Anti-inflammatory effect  Immunosuppressive effect  Increase the response to catecholamines  Inhibit the activity of PDE  Adenoceptor-upregulation

//Route of administration : orally i.v used for : severe asthma status asthmaticus metered dose inhaler //Indications : Because of the efficacy and safety of inhaled corticosteroids, they are now routinely prescribed for patients who require more than occasional inhalations of β agonist for relief of symptom.

// Adverse effect:  Oropharyngeal candidiasis it can be reduced by having patients gargle water and spit after each inhaled treatment.  Hoarseness

Ⅴ. Anti-allergic agents i.e. mast-cell-stabilizers cromolyn sodium ( 色甘酸钠 ) //Mechanism : They appear to stabilize antigen-sensitized mast cell by reducing calcium influx and subsequent release of inflammatory mediators.

 On mast cells, for inhibition of the early response to antigen challenge  On eosinophils, for inhibition of the inflammatory response to inhalation of allergens

// Route of administration : metered dose inhaler of cromoly sodium // Indications : pretreatment with cromolyn blocks the bronchoconstriction caused by antigen inhalation,by exercise, by aspirin, and by a variety of cause of occupational asthma.

// Adverse effect  Throat irritation  Cough  Mouth dryness  Chest tightness and so forth